HOME > メンバー(中村研究室) > メンバー(片桐チーム)
片桐豊雅 プロフィール

【氏   名】 片桐豊雅(かたぎり とよまさ)/ Toyomasa Katagiri, Ph.D.

【生年月日】 昭和40年10月21日(兵庫県神戸市出身)

【現  職】 東京大学医科学研究所  ヒトゲノム解析センター・シークエンス技術開発分野 助教授

【専門分野】 腫瘍医学

【連 絡 先】
〒108-8639 東京都港区白金台4-6-1 総合研究棟7階
東京大学医科学研究所 ヒトゲノム解析センター・シークエンス技術開発分野
e-mail : tkatagi@ims.u-tokyo.ac.jp

【略  歴】
平成 3年 3月 香川大学大学院 農学研究科修士課程修了
平成 3年 4月 大塚製薬株式会社 研究員
平成 4年10月 (財) 癌研究会 癌研究所 生化学部(中村祐輔部長)研究生として国内留学
平成 4年10月 (財) 癌研究会 癌研究所 生化学部(中村祐輔部長)研究生として国内留学
平成 7年10月 (財) 癌研究会 癌化学療法センター ゲノム解析研究部 研究員
平成10年 4月 大阪大学医学部 医学博士号取得
平成10年10月 英国ロンドン大学ガイズ・キングス・セントトーマス校医学部
(Prof. Ellen Solomon) 研究員
平成13年 1月 東京大学医科学研究所ヒトゲノム解析センター 助手
平成16年 5月 東京大学医科学研究所ヒトゲノム解析センター 助教授

【所属学会】 日本癌学会、アメリカ癌学会

【受 賞 歴】 平成16年 第63回日本癌学会奨励賞

【論文リスト】 (2007年4月現在)

  1. Kanehira M, Harada Y, Takata R, Shuin T, Miki T, Fujioka T, Nakamura Y, Katagiri T. Oncogene 2007, in press.

  2. Kanehira M, Katagiri T, Shimo A, Takata R, Shuin T, Miki T, Fujioka T Nakamura Y. Oncogenic role of MPHOSPH1, a cancer-testis antigen specific to human bladder cancer. Cancer Res. 2007, in press.

  3. Lin ML, Park JH, Nishidate T, Nakamura Y, Katagiri T. MELK, maternal embryonic leucine zipper kinase, involved in mammary carcinogenesis through interaction with Bcl-G, a pro-apoptotic member of Bcl-2 family. Breast Cancer Res. 2007 in press.

  4. Shimo A, Nishidate T, Ohta T, Fukuda M, Nakamura Y, Katagiri T. Elevated expression of PRC1, protein regulator of cytokinesis 1, involved in the growth of breast cancer cells. Cancer Sci. 98:174-181, 2007.

  5. Takata R, Katagiri T, Kanehira M, Shuin T, Miki T, Namiki M, Kohri K, Tsunoda T, Fujioka T, Nakamura Y. Validation study of the prediction system for clinical response of M-VAC neoadjuvant chemotherapy. Cancer Sci. 98:113-117, 2006.

  6. Park JH, Lin ML, Nishidate T, Nakamura Y, Katagiri T. PDZ-binding kinase/T-LAK cell-originated protein kinase, a putative cancer/testis antigen having an oncogenic activity in breast cancer. Cancer Res. 66:9186-9195, 2006.

  7. Iiizumi M, Hosokawa M, Takehara A, Chung S, Nakamura T, Katagiri T, Eguchi H, Ohigashi H, Ishikawa O, Nakamura Y, Nakagawa H. EphA4 receptor, overexpressed in pancreatic ductal adenocarcinoma, promotes cancer cell growth. Cancer Sci. 97:1211-1216, 2006.

  8. Takehara A, Eguchi H, Ohigashi H, Ishikawa O, Kasugai T, Hosokawa M, Katagiri T, Nakamura Y, Nakagawa H. Novel tumor marker REG4 detected in serum of patients with resectable pancreatic cancer and feasibility for antibody therapy targeting REG4. Cancer Sci. 97:1191-1197, 2006.

  9. Hirota E, Yan L, Tsunoda T, Ashida S, Fujime M, Shuin T, Miki T, Nakamura Y, Katagiri T. Genome-wide gene expression profiles of clear cell renal cell carcinoma; Identification of molecular targets for treatment of renal cell carcinoma. Int J Oncol 29:799-827, 2006.

  10. Ashida S, Furihata M, Katagiri T, Tamura K, Anazawa Y, Yoshioka M, Miki T, Fujioka T, Shuin T, Nakamura Y, Nakagawa H. Expression of novel molecules, MICAL2-PV (MICAL2 prostate cancer variants), increases with high Gleason score and prostate cancer progression. Clin Cancer Res. 12:2767-2773, 2006.

  11. Hamamoto R, Silva FP, Tsuge M, Nishidate T, Katagiri T, Nakamura Furukawa Y. Enhanced SMYD3 expression is essential for the growth of breast cancer cells. Cancer Sci. 97:113-118, 2006.

  12. Kikuchi T, Daigo Y, Ishikawa N, Katagiri T, Tsunoda T, Yoshida S, Nakamura Y. Expression profiles of metastatic brain tumor from lung adenocarcinomas on cDNA microarray. Int J Oncol. 4:799-805, 2006

  13. Fukukawa C, Nakamura Y, Katagiri T. Molecular target therapy for synovial sarcoma. Future Oncology 1:805-812, 2005.

  14. Morris JR, Pangon L, Boutell C, Katagiri T, Keep NH, Solomon E. Genetic analysis of BRCA1 ubiquitin ligase activity and its relationship to breast cancer susceptibility. Hum Mol Genet. 15:599-606, 2006.

  15. Tachiiri S, Katagiri T, Tsunoda T, Oya N, Hiraoka M, Nakamura Y. Analysis of gene-expression profiles after gamma irradiation of normal human fibroblasts. Int J Radiat Oncol Biol Phys. 64:272-279, 2006.

  16. Anazawa Y, Nakagawa H, Furihara M, Ashida S, Tamura K, Yoshioka H, Shuin T, Fujioka, Katagiri T, Nakamura Y. Analysis of gene-expression profiles after gamma irradiation of normal human fibroblasts. PCOTH, a novel gene overexpressed in prostate cancers, promotes prostate cancer cell growth through phosphorylation of oncoprotein TAF-Ibeta/SET. Cancer Res. 65:4578-4586, 2005.

  17. Obama K, Ura K, Li M, Katagiri T, Tsunoda T, Nomura A, Satoh S, Nakamura Y, Furukawa Y. Genome-wide analysis of gene expression in human intrahepatic cholangiocarcinoma. Hepatology, 41:1339-1348, 2005.

  18. Nagayama S, Fukukawa C, Katagiri T, Okamoto T, Aoyama T, Oyaizu N, Imamura M, Toguchida J, Nakamura Y: Therapeutic potential of antibodies against FZD10, a cell-surface protein, for synovial sarcomas: Oncogene, 24:6201-6212,2005

  19. Togashi A, Katagiri T, Ashida S, Fujioka T, Maruyama O, Wakumoto Y, Sakamoto Y, Fujime M, Kawachi Y, Shuin T, Nakamura Y: Hypoxia-inducible protein 2 (HIG2), a novel diagnostic marker for renal cell carcinoma (RCC) and potential target for molecular therapy. Cancer Res., 65:4817-4826, 2005

  20. Takata R, Katagiri T, Kanehira M, Tsunoda T, Shuin T, Miki T, Namiki M, Kohri K, Matsushita Y, Fujioka T, Nakamura Y: Predicting response to methotrexate, vinblastine, doxorubicin, and cisplatin neoadjuvant chemotherapy for bladder cancers through genome-wide gene expression profiling. Clin. Cancer Res., 11:2625-2636, 2005

  21. Ishibe T, Nakayama T, Okamoto T, Aoyama T, Nishijo K, Shibata KR, Shima Y, Nagayama S, Katagiri T, Nakamura Y, Nakamura Tdd and Toguchida J: Disruption of fibroblast growth factor signal pathway inhibits the growth of synovial sarcomas: potential application of signal inhibitors to molecular target therapy. Clin. Cancer Res., 11:2702-2712, 2005

  22. Taniuchi K, Nakagawa H, Hosokawa M, Nakamura T, Eguchi H, Ohigashi H, Ishikawa O, Katagiri T and Nakamura Y: Overexpressed P-cadherin/CDH3 promotes motility of pancreatic cancer cells by interacting with p120ctn and activating rho-family GTPases.K. Cancer Res., 65:3092-3099, 2005

  23. Taniuchi K, Nakagawa H, Nakamura T, Eguchi H, Ohigashi H, Ishikawa O, Katagiri T, Nakamura Y: Down-regulation of RAB6KIFL/KIF20A, a kinesin involved with membrane trafficking of discs large homologue 5, can attenuate growth of pancreatic cancer cell. Cancer Res., 65:105-112. 2005.

  24. Nakatsura T, Komori H, Kubo, Y. Yoshitake, S. Senju, Katagiri T, Furukawa Y, Ogawa M, Nakamura Y, Nishimura Y: Mouse homologue of a novel human oncofetal antigen, glypican-3, evokes T-cell-mediated tumor rejection without autoimmune reactions in mice. Clin. Cancer Res., 10:8630-8640, 2004

  25. Kamiyama H, Kurosaki, K, Kurimoto M, Katagiri T, Nakamura Y, Kurokawa M, H. Sato, S. Endo and K. Shiraki: Herpes simplex virus-induced, death receptor-dependent apoptosis and regression of transplanted human cancers. Cancer Sci., 95:990-998, 2004

  26. Okada K, Hirota E, Mizutani Y, Fujioka T, Shuin T, Miki T, Nakamura Y, Katagiri T: Oncogenic role of NALP7 in testicular seminomas. Cancer Sci., 95:949-954, 2004

  27. Yoshitake Y, Nakatsura T, Monji M, Senju S, Matsuyoshi H, Tsukamoto H, Hosaka S, Komori H, Fukuma D, Ikuta Y, Katagiri T, Furukawa Y, Ito H, Shinohara M, Nakamura Y, Nishimura Y: Proliferation potential-related protein, an ideal esophageal cancer antigen for immunotherapy, identified using complementary DNA microarray analysis. Clin. Cancer Res., 10:6437-6448, 2004

  28. Nishidate T, Katagiri T, Lin ML, Mano Y, Miki Y, Kasumi F, Yoshimoto M, Tsunoda T, Hirata K, Nakamura Y: Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis. Int. J. Oncol., 25:797-819, 2004

  29. Ashida S, Nakagawa H, Katagiri T, M. Furihata, M. Iiizumi, Y. Anazawa, Tsunoda T, R. Takata, K. Kasahara, T. Miki, T. Fujioka, T. Shuin and Nakamura Y: Molecular features of the transition from prostatic intraepithelial neoplasia (PIN) to prostate cancer: genome-wide gene-expression profiles of prostate cancers and PINs. Cancer Res., 64:5963-5972, 2004

  30. Harima Y, Togashi A, Horikoshi K, Imamura M, Sougawa M, Sawada S, Tsunoda T, Nakamura Y, Katagiri T: Prediction of outcome of advanced cervical cancer to thermoradiotherapy according to expression profiles of 35 genes selected by cDNA microarray analysis. Int J Radiat Oncol Biol Phys., 60:237-248, 2004

  31. Nagayama S, Iiizumi M, Katagiri T, Toguchida J, Nakamura Y: Identification of PDZK4, a novel human gene with PDZ domains, that is up-regulated in synovial sarcomas. Oncogene, 23:5551-5557, 2004

  32. Ochi K, Daigo Y, Katagiri T, Nagayama S, Tsunoda T, Myoui A, Naka N, Araki N, Kudawara I, Ieguchi M, Toyama Y, Toguchida J, Yoshikawa H, Nakamura Y: Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. Int. J. Oncol., 24:647-655, 2004

  33. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, H. Ohigashi, K. Murata, O. Ishikawa, K. Ohgaki, N. Kashimura, M. Miyamoto, S. Hirano, S. Kondo, H. Katoh, Nakamura Y and Katagiri T: Genome-wide cDNA microarray analysis of gene-expression profiles in pancreatic cancers using populations of tumor cells and normal ductal epithelial cells selected for purity by laser microdissection. Oncogene, 23:2385-2400, 2004

  34. Li M, Lin YM, Hasegawa S, Shimokawa T, Murata K, Kameyama M, Ishikawa O, Katagiri T, Tsunoda T, Nakamura Y, Furukawa Y: Genes associated with liver metastasis of colon cancer, identified by genome-wide cDNA microarray. Int J Oncol., 24: 305-312. 2004

  35. Okada K, Katagiri T, Tsunoda T, Mizutani Y, Suzuki Y, Kamada M, Fujioka T, Shuin T, Miki T, Nakamura Y: Analysis of gene-expression profiles in testicular seminomas using a genome-wide cDNA microarray. Int J Oncol., 23:1615-1635, 2003

  36. Suzuki C, Daigo Y, Kikuchi T, Katagiri T, Nakamura Y: Identification of COX17 as a therapeutic target for non-small cell lung cancer. Cancer Res., 63:7038-7041, 2003

  37. Kaneta Y, Kagami Y, Tsunoda T, Ohno R, Nakamura Y, Katagiri T: Genome-wide analysis of gene-expression profiles in chronic myeloid leukemia cells using a cDNA microarray. Int J Oncol., 23:681-691, 2003

  38. Zembutsu H, Ohnishi Y, Daigo Y, Katagiri T, Kikuchi T, Kakiuchi S, Nishime C, Hirata K, Nakamura Y: Gene-expression profiles of human tumor xenografts in nude mice treated orally with the EGFR tyrosine kinase inhibitor ZD1839. Int J Oncol., 23:29-39, 2003

  39. Nakatsura T, Yoshitake Y, Senju S, Monji M, Komori H, Motomura Y, Hosaka S, Beppu T, Ishiko T, Kamohara H, Ashihara H, Katagiri T, Furukawa Y, Fujiyama S, Ogawa M, Nakamura Y, Nishimura Y: Glypican-3, overexpressed specifically in human hepatocellular carcinoma, is a novel tumor marker. Biochem Biophys Res Commun., 306:16-25, 2003.

  40. Ochi K, Daigo Y, Katagiri T, Saito-Hisaminato A, Tsunoda T, Toyama Y, Matsumoto H, Nakamura Y: Expression profiles of two types of human knee-joint cartilage. J Hum Genet., 48:177-182, 2003

  41. Kikuchi T, Daigo Y, Katagiri T, Tsunoda T, Okada K, Kakiuchi S, Zembutsu H, Furukawa Y, Kawamura M, Kobayashi K, Imai K, Nakamura Y: Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs. Oncogene, 22:2192-2205, 2003.

  42. Arimoto T, Katagiri T, Oda K, Tsunoda T, Yasugi T, Osuga Y, Yoshikawa H, Nishii O, Yano T, Taketani Y, Nakamura Y: Genome-wide cDNA microarray analysis of gene-expression profiles involved in ovarian endometriosis. Int J Oncol., 22:551-560, 2003

  43. Abe S, Katagiri T, Saito-Hisaminato A, Usami S, Inoue Y, Tsunoda T, Nakamura Y: Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Identification of CRYM as a candidate responsible for nonsyndromic deafness, through cDNA microarray analysis of human cochlear and vestibular tissues. Am J Hum Genet., 72:73-82, 2003

  44. Okutsu J, Tsunoda T, Kaneta Y, Katagiri T, Kitahara O, Zembutsu H, Yanagawa R, Miyawaki S, Kuriyama K, Kubota N, Kimura Y, Kubo K, Yagasaki F, Higa T, Taguchi H, Tobita T, Akiyama H, Takeshita A, Wang Y, Motoji T, Ohno R, Nakamura Y: Prediction of chemosensitivity for patients with acute myeloid leukemia, according to expression levels of 28 genes selected by genome-wide complementary DNA microarray analysis. Mol Cancer Ther., 1:1035-1042, 2002

  45. Hasegawa S, Furukawa Y, Li M, Satoh S, Kato T, Watanabe T, Katagiri T, Tsunoda T, Yamaoka Y, Nakamura Y: Genome-wide analysis of gene expression in intestinal-type gastric cancers using a complementary DNA microarray representing 23,040 genes. Cancer Res., 62:7012-7017, 2002

  46. Nagamaya S, Katagiri T, Tsunoda T, Hosaka T, Nakashima Y, Araki N, Kusuzaki K, Nakayama T, Tsuboyama T, Nakamura T, Imamura M, Nakamura Y, Toguchida J: Genome-wide analysis of gene expression in synovial sarcomas using a cDNA microarray. Cancer Res., 62: 5859-5866, 2002

  47. Brown M, Nicolai H, Howe K, Katagiri T, Lalani E, Simpson K, Manning N, Deans A, Chen P, Khanna KK, Wati MR, Griffiths B, Xu C, Stamp G, Solomon E: Expression of a truncated Brca1 protein delays lactational mammary development in transgenic mice. Transgenic Res., 11: 467-478, 2002

  48. Kaneta Y, Kagami Y, Katagiri T, Tsunoda T, Jin-nai I, Taguchi H, Hirai H, Ohnishi K, Ueda T, Emi N, Tomida A, Tsuruo T, Nakamura Y, R. Ohno: Prediction of sensitivity to STI571 among chronic myeroid leukemia patients by genome-wide cDNA microarray analysis. Jpn J Cancer Res., 93: 849-856, 2002

  49. Kitahara O, Katagiri T, Tsunoda T, Harima Y, Nakamura Y: Classification of sensitivity or resistance of cervical cancers to ionizing radiation according to expression profiles of 62 genes selected by cDNA microarray analysis. Neoplasia, 4: 295-303, 2002

  50. Saito-Hisaminato A, Katagiri T, Kakiuchi S, Nakamura T, Tsunoda T, Nakamura Y: Genome-wide profiling of gene expression in 29 normal human tissues with a cDNA microarray. DNA Res., 9: 35-45, 2002

  51. K. Miura, E. D. Bowman, R. Simon, A. C. Peng, A. I. Robles, R. T. Jones, Katagiri T, P. He, H. Mizukami, L. Charboneau, T. Kikuchi, L. A. Liotta, Nakamura Y, and C. C. Harris: Laser capture microdissection and microarray expression analysis of lung adenocarcinoma reveals tobacco smoking and prognosis-related molecular profiles. Cancer Res., 62: 3244-3250, 2002

  52. S. Dan, Tsunoda T, O. Kitahara, R. Yanagawa, H. Zembutsu, Katagiri T, K. Yamazaki, Nakamura Y and T. Yamori: An integrated database of chemosensitivity to 55 anticancer drugs. Cancer Res., 62:1139-1147, 2002

  53. Zembutsu H, Ohnishi Y, Tsunoda T, Furukawa Y, Katagiri T, Ueyama Y, Tamaoki N, Nomura T, Kitahara O, Yanagawa R, Hirata K, Nakamura Y: Genome-wide cDNA microarray screening to correlate gene expression profiles with sensitivity of 85 human cancer xenografts to anticancer drugs. Cancer Res., 62: 518-527, 2002

  54. Maeda K, Matsuhashi S, Tabuchi K, Watanabe T, Katagiri T, Oyasu M, Saito N, Kuroda S: Brain specific human genes, NELL1 and NELL2, are predominantly expressed in neuroblastoma and other embryonal neuroepithelial tumors. Neurol Med Chir., 41:582-588, 2001

  55. Kato M, Yano K, Matsuo F, Saito H, Katagiri T, Kurumizaka H, Yoshimoto M, Kasumi F, Akiyama F, Sakamoto G, Nagawa H, Nakamura Y, Miki Y: Identification of Rad51 alteration in patients with bilateral breast cancer. J Human Genet., 45:133-137, 2000

  56. Futamura M, Arakawa H, Matsuda K, Katagiri T, Saji S, Miki Y, Nakamura Y: Potential role of BRCA2 in a mitotic checkpoint after phosphorylation by hBUBR1. Cancer Res., 60:1531-1535, 2000.

  57. Emi M, Yoshimoto M, Sato T, Matsumoto S, Y. Utada, I. Ito, K. Minobe, T. Iwase, Katagiri T, Bando K, Akiyama F, Harada Y, Fukino K, Sakamoto G, Matsushima M, Iida A, Tada T, Saito H, Miki Y, Kasumi F, Nakamura Y: Allelic loss at 1p34, 13q12, 17p13.3, and 17q21.1 correlates with poor postoperative prognosis in breast cancer. Genes Chromosomes Cancer, 26:134-141, 1999.

  58. Katagiri T, Futamura M, Nakamura Y: A Gln/Arg polymorphism at codon 349 of the hBUBR1 gene. J Human Genet., 44:131-132, 1999

  59. Maruyama O, Nishimori H, Katagiri T, Miki Y, Ueno A, Nakamura Y: Cloning of TCFL5 encoding a novel human basic helix-loop-helix motif protein that is specifically expressed in primary spermatocytes at the pachytene stage. Cytogenet Cell Genet., 82:41-45, 1998

  60. Katagiri T, Saito H, Shinohara A, Ogawa H, Kamada N, Nakamura Y, Miki Y: Multiple possible sites of BRCA2 interacting with DNA repair protein Rad51. Genes Chromosomes Cancer, 21:217-222, 1998

  61. Katagiri T, Kasumi F, Yoshimoto M, Asaishi K, Abe R, Tsuchiya A, Sugano M, Nomizu T, Takai S, Yoneda M, Nanba K, Makita M, Okazaki H, Hirata K, Okazaki M, Furutsuma Y, Morishita Y, Iino Y, Karino T, Fukutomi T, Ayabe H, Hara S, Kajiwara T, Houga S, Shimizu T, Toda M, Yamasaki Y, Uchida T, Kunitomo K, Sonoo H, Kurebayashi J, Shimotuma K, Nakamura Y, Miki Y: High proportion of missense mutations of the BRCA1 and BRCA2 genes in Japanese breast cancer families. J Human Genet., 43:42-48, 1998

  62. Emi M, Matsushima M, Katagiri T, Yokota T, Nakata T, Kasumi F, Miki Y, Skolnick MH, Nakamura Y: Multiplex mutation screening of the BRCA1 gene in 1000 Japanese breast cancers: 2-3% of Japanese breast cancer is attributable to BRCA1 mutations. Jpn J Cancer Res., 89:12-14, 1998

  63. Miki Y, Katagiri T, Nakamura Y: Infrequent mutation of the H-Cadherin gene on chromosome 16q24 in human breast cancers. Jpn J Cancer Res., 88:701-704, 1997

  64. Shimizu F, Katagiri T, Suzuki M, Watanabe TK, Okuno S, Kuga Y, Nagata M, Fujiwara T, Nakamura Y, Takahashi E: Cloning and chromosome assignment to 1q32 of a human cDNA (RAB7L1) encoding a small GTP-binding protein, a member of the RAS superfamily. Cytogenet Cell Genet., 77: 261-263,1997

  65. Watanabe TK, Katagiri T, Suzuki M, Shimizu F, Fujiwara T, Kanemoto N, Nakamura Y, Hirai Y, Maekawa H, Takahashi E: Cloning and characterization of two novel human cDNAs (NELL1 and NELL2) encoding proteins with six EGF-like repeats. Genomics, 38: 273-276, 1996

  66. Katagiri T, Ozaki K, Fujiwara T, Shimizu F, Kawai A, Okuno S, Suzuki M, Nakamura Y, Takahashi E, Hirai Y: Cloning, expression, and chromosome mapping of adducin-(alpha) like 1 (ADDL1), a human cDNA highly homologous to human erythrocyte adducin. Cytogenet Cell Genet., 74: 90-95,1996

  67. Katagiri T, Miki Y, Nakamura Y: Mutations in the BRCA2 gene in hepatocellular carcinomas. Cancer Res., 56: 4575-4577, 1996

  68. Miki Y, Katagiri T, Kasumi F, Yoshimoto T, Nakamura Y: Mutation analysis in the BRCA2 gene in primary breast cancers. Nature Genet., 13: 245-247, 1996

  69. Katagiri T, Emi M, Ito I, Kobayashi K, Yoshimoto M, Watanabe S, Iwase T, Kasumi F, Miki Y, Skolnick MH, Nakamura Y: Mutations in the BRCA1 gene in Japanese breast cancer patients. Human Mutat., 7: 334-339, 1996

  70. I. Ito, Yoshimoto M, T. Iwase, S. Watanabe, Katagiri T, Harada Y, Kasumi F, S. Yasuda, T. Mitomi, Emi M and Nakamura Y: Association of genetic alterations on chromosome 17 and loss of hormone receptors in breast cancer. Br J Cancer, 71: 438-441, 1995

  71. Katagiri T, Harada Y, Emi M, Nakamura Y: Human metalloprotease/ disintegrin-like (MDC) gene: exon-intron organization and alternative splicing. Cytogenet Cell Genetics., 68: 39-44,1995

  72. Harada Y, Katagiri T, I. Ito, F. Akiyama, G. Sakamoto, Kasumi F, Nakamura Y and Emi M: Genetic studies of 457 breast cancers. Clinicopathologic parameters compared with genetic alterations. Cancer, 74: 2281-2286, 1994

  73. Isomura M, Tanigami A, Saito H, Harada Y, Katagiri T, Inazawa J, Ledbetter DH, Nakamura Y: Detailed analysis of heterozygosity on chromosome band 17p13 in breast carcinoma on the basis of a high-resolution physical map with 29 markers. Genes Chromosomes Cancer, 9: 173-179,1994

  74. Emi M, Katagiri T, Harada Y, Saito H, Inazawa J, Ito I, Kasumi F, Nakamura Y: A novel metalloprotease/ disintegrin-like gene at 17q21.3 is somatically rearranged in two primary breast cancers. Nature Genet., 5: 151-157,1993

  75. Ichii M, Katagiri T, Hasegawa H, Yatou O, Kirk DW, Wray JL: Biochemical characterization of rice (Oryza sativa L.) mutants defective or low in nitrate reduction. Tech. Bull. Fac. Agric., Kagawa University 47:1–6, 1995

  76. Ichii M, Katagiri T, Hasegawa H. Mutants with low nitrate reductase activity selected from seedlings expressing nitrogen deficiency symptoms in rice (Oryza sativa L.). Jpn. J. Breed., 43:123–127, 1993.

  77. Hasegawa H, Katagiri T, Ida S, Yatou O, Ichii M: Characterization of a rice (Oryza sativa L.) mutant deficient in the heme domain of nitrate reductase. Theor. Appl. Genet., 84: 6-9, 1992

  78. Hasegawa H, Yatou O, Katagiri T, Ichii M, Screening for nitrate reductase deficient mutants in rice (Oryza sativa L.). Jpn. J. Breed., 41: 95-101, 1991.

Copyright © 2007 Yusuke Nakamura's Labo., All rights reserved.
Last update: 2007.4.3

↑ Page top